Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 November 2019 | Story Leonie Bolleurs | Photo Leonie Bolleurs
Farmovs
At a first for South Africa, the SACRA clinical trials capacity-building workshop with government, research institutions, and industry, were from the left: Dr Nathaniel Mofolo, Dr Rita Nathan, Dr Mojalefa Maseloa (Head: Clinical Services in the Clinical Unit at the Universitas Hospital) and Sue Baily (Site Management Head at IQVIA).

Whether it is to treat the flu or a more serious illness, all medicines go through a very costly and lengthy research process before being approved for prescription to patients. The cumulative time from the beginning of trials to marketing approval has increased over the past ten years. 

According to Dr Vathi Papu-Zamxaka from the South African Clinical Research Association (SACRA), South Africans would not have had access to safe and effective medicines, had it not been for the intensive research conducted on new medicines. 

On 7 November 2019, a group of 115 delegates representing the Free State Department of Health, the UFS, private research sites, and the pharmaceutical industry met at FARMOVS on the Bloemfontein Campus of the University of the Free State (UFS) for the SACRA clinical trials capacity-building workshop.

2,1 billion dollars to develop one successful drug

Dr Michelle Middle, Chief Medical Officer at FARMOVS, provided some interesting stats on the process for drugs to hit the shelves: “One out of 10 drugs entering human research will be approved. The cost of development of one successful drug is approximately 2,1 billion dollars. And the time to develop a drug, from submission of the Investigational New Drug Application (IND) to approval by the Food and Drug Administration (FDA), is between 12 and 15 years.”

Dr Middle stated that drug development is one of the most regulated processes, with ethics and patient safety governing the undertaking. “With SAHPRA (South African Health Products Regulatory Agency) having some of the strictest regulations in the world, South Africa has a good history of running trials.  In addition, fast growth is expected for the pharmaceutical market on the African continent, necessitating the need for increased clinical trials on this continent,” she said. 

Very few clinical trials hosted in South Africa 

Although Africa has the broadest genetic variability of all human populations and carries 17% of the global population, very few clinical trials are hosted on the continent. Globally, there are currently approximately 322 000 clinical trials being actively conducted, of which only 1 700 are conducted in Africa, i.e. less than 3%.  Even worse, only 304 of the 1 700 trials running in Africa are conducted in South Africa.  There is thus a critical need for South Africa as a country to market itself as a clinical trial destination and to attract more trials to the country.

South Africa’s competitive edge lies in being known for its ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use)-compliant top-quality research, racial and genetic diverse trial participants, good medical infrastructure and expertise, and the good reputation of the regulator (SAHPRA). “There are, however, a need for transformation and capacity building in clinical research in the country,” said Dr Middle. 

Dr Rita Nathan, Head of Clinical Services in the Clinical Department at the Universitas Hospital, who was representing government at the workshop, is looking to strengthen clinical trials across government and industry by focusing on, among others, funding models, operations management, and service delivery. 

From the UFS Faculty of Health Sciences, Dr Nathaniel Mofolo, Head of the School of Clinical Medicine, said collaboration between stakeholders is important. “This initiative is giving direction to the UFS vision of being a research-led university.” 

Other topics discussed at the workshop include the clinical trials landscape, how clinical trials work, the patient factor, ethics in clinical trials, and the economic aspect of clinical trials. 

News Archive

Huge interest in Ms Oprah Winfrey's visit to our university
2011-06-10

 

Staff and students from our Bloemfontein Campus queued since early this morning to obtain their tickets.
Photo: Phelekwa Mpono

The atmosphere on our campuses is electric with the upcoming visit and Graduation Ceremony of Ms Oprah Winfrey in Bloemfontein.

Ms Winfrey will receive an Honorary Doctorate in Education from our university on Friday, 24 June 2011.

Every single ticket for the event was snapped up within hours of becoming available this morning (Wednesday, 15 June 2011). Staff and students queued in front of the Information Centre on our university’s Bloemfontein Campus to get their free tickets, while the general public did the same at Computicket outlets throughout the country.

The university would like to thank everyone for their positive attitude and eagerness to be part of this special day. A special thank you to all our staff and students who have volunteered their services and are helping to plan and manage the event.

The university requests everyone who has managed to secure a ticket to ensure that they arrive early on the Bloemfontein Campus that day.

On Friday, 24 June 2011, the doors of the Callie Human Centre will open for both special guests and the public in general at 13:00. The doors will close strictly at 14:00 and no one will be allowed to enter or leave the building for reasons of safety and security.

Entertainment before and after the Graduation Ceremony will be provided by acclaimed musicians such as the internationally lauded, award-winning singer Sibongile Khumalo, the Botshabelo String Orchestra, the Bloemfontein Children’s Choir and the choir of the Bartimea School for the Deaf and Blind.

After the Graduation Ceremony, Ms Winfrey will formally address the 4 500 guests, after which she will conduct a Question-and-Answer Session with students from the large audience. 


Media Release
15 June 2011
Issued by: Lacea Loader
Director: Strategic Communication
Tel: 051 401 2584
Cell: 083 645 2454
E-mail: news@ufs.ac.za

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept